Breast Cancer is the 2nd leading cause of death by cancer (Lung cancer is first) in women. Studies have also shown that the 5 year survival rate for female breast cancer has increased from 63% during the ‘60s to about 90% currently based on faster and more precise diagnosis and new treatments.

The Breast Cancer Exploratory Tissue Microarray (TMA) is designed as a comprehensive slide based TMA which incorporates samples of different cancerous, normal, normal adjacent, and different species of breast tissues.